LifeStance Health Group, Inc.

Equities

LFST

US53228F1012

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
5.81 ^USD	-22.33%		-22.43%	-25.80%

May. 22	Top Midday Decliners	MT
May. 22	Sector Update: Health Care Stocks Advance Wednesday Afternoon	MT

LifeStance Health Group, Inc. Provides Earnings Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024

May 09, 2024 at 06:00 am EDT

LifeStance Health Group, Inc. provided earnings guidance for the second quarter of 2024. For the second quarter of 2024, the company expects total revenue of $297 to $315 million.

The company is reiterating full year revenue of $1.19 billion to $1.24 billion.

Latest news about LifeStance Health Group, Inc.

Top Midday Decliners	May. 22	MT
Sector Update: Health Care Stocks Advance Wednesday Afternoon	May. 22	MT
LifeStance Health Group Prices Secondary Stock Offering; Shares Plunge	May. 22	MT
Sector Update: Health Care Stocks Lower Premarket Wednesday	May. 22	MT
Traders Cautious Ahead of Fed Minutes, Nvidia Earnings, Stifling US Equity Futures Pre-Bell	May. 22	MT
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Ahead of Fed Meeting Minutes, Nvidia Earnings	May. 22	MT
Top Premarket Decliners	May. 22	MT
LifeStance Health Group Prices Secondary Stock Offering; Shares Plunge Premarket	May. 22	MT
LifeStance Health Group Secondary Stock Offering Priced	May. 22	MT
LifeStance Health Discloses Secondary Public Offering	May. 21	MT
Lifestance Health Group Insider Sold Shares Worth $362,567, According to a Recent SEC Filing	May. 14	MT
Transcript : LifeStance Health Group, Inc., Q1 2024 Earnings Call, May 09, 2024	May. 09
LifeStance Health Q1 Loss Narrows as Revenue Increases; 2024 Revenue Outlook Reiterated	May. 09	MT
LifeStance Health Group, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
LifeStance Health Group, Inc. Announces Resignation of Danish Qureshi as President and Chief Operating Officer, Effective June 30, 2024	May. 09	CI
Earnings Flash (LFST) LIFESTANCE HEALTH Posts Q1 Revenue $300.4M, vs. Street Est of $299M	May. 09	MT
LifeStance Health Group, Inc. Provides Earnings Guidance for the Second Quarter of 2024; Reiterates Earnings Guidance for the Full Year of 2024	May. 09	CI
LifeStance Health Appoints Teresa DeLuca to Its Board of Directors	Mar. 12	CI
Jefferies Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Buy Rating	Mar. 06	MT
Lifestance Health Group Insider Sold Shares Worth $923,391, According to a Recent SEC Filing	Mar. 05	MT
Goldman Sachs Adjusts Price Target on LifeStance Health to $9 From $8, Maintains Neutral Rating	Mar. 04	MT
UBS Adjusts LifeStance Health Group Price Target to $9 From $7, Maintains Neutral Rating	Feb. 29	MT
Barclays Adjusts LifeStance Health Group Price Target to $8 From $7, Maintains Underweight Rating	Feb. 29	MT
Sector Update: Health Care Stocks Decline Late Afternoon	Feb. 28	MT
Sector Update: Health Care Stocks Softer Wednesday Afternoon	Feb. 28	MT

Chart LifeStance Health Group, Inc.

Duration

Period

More charts

Company Profile

LifeStance Health Group, Inc. is a mental healthcare company. The Company is focused on providing of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions. Its clinicians provide services spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family and group therapy. The Company treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. It uses evidence-based approaches to ensure effective treatment. The Company offers patients the ability to conduct a given visit with their clinician virtually. It has around 6,645 employed psychiatrists, APNs, psychologists, and therapists. It employs approximately 6,600 psychiatrists, advanced practice nurses, psychologists and therapists and operates across 33 states and more than 550 centers.

Sector

Healthcare Facilities & Services

Calendar

2024-06-02 - Annual General Meeting

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for LifeStance Health Group, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

5.81 USD

Average target price

8.786 USD

Spread / Average Target

+51.22%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
LIFESTANCE HEALTH GROUP, INC.	-25.80%	2.22B
HCA HEALTHCARE, INC.	+17.63%	83.4B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.35%	27.04B
LABCORP HOLDINGS INC.	-11.48%	16.96B
FRESENIUS SE & CO. KGAA	-0.29%	16.86B
QUEST DIAGNOSTICS INCORPORATED	+2.89%	15.76B
REDE D'OR SÃO LUIZ S.A.	+1.25%	12.76B
NATERA, INC.	+73.23%	13.33B
TENET HEALTHCARE CORPORATION	+72.58%	12.74B
FRESENIUS MEDICAL CARE AG	+1.48%	12.32B

Other Healthcare Facilities & Services